(Q51514519)

6 April 2018

title

Insulin glargine: the first clinically useful extended-acting insulin in half a century? (English)

1 reference

6 April 2018

1 reference

1 reference

Home P

1

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

6 April 2018

Expert Opinion on Investigational Drugs

published in

1 reference

6 April 2018

volume

8

1 reference

6 April 2018

issue

3

1 reference

6 April 2018

page(s)

307-314

1 reference

6 April 2018

Relation of diabetic control to development of microvascular complications

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.307

Characterization of proinsulin-insulin intermediates in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.307

NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.307

In vitro activity of biosynthetic human diarginylinsulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.307

Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.307

The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.307

21 January 2018

Identifiers

DOI

10.1517/13543784.8.3.307

1 reference

6 April 2018

PubMed ID

15992080

1 reference

6 April 2018